查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927696

全球生命科学分析人工智慧市场：按产品、部署方式、应用、最终用户、国家和地区划分－产业分析、市场规模、份额和预测（2025-2032年）

AI In Life Science Analytics Market, By Offering, By Deployment Mode, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 310 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，生命科学分析领域的 AI 市场规模将达到 21.053 亿美元，从 2025 年到 2032 年的复合年增长率将达到 11.45%。

生命科学分析领域的人工智慧市场主要利用人工智慧（例如机器学习、自然语言处理和各种生成式人工智慧工具）来处理生命科学公司面临的大量数据，并更有效率地做出更明智的决策。製药和生物技术公司从各种来源收集数据，包括基因组学/体学研究、实验室检测、临床试验、安全报告、科学论文以及电子健康记录(EHR) 和保险索赔数据等真实世界数据。挑战在于，这些数据通常分散且非结构化（例如医生笔记和医学文献）。人工智慧可以透过发现模式、预测结果和自动化分析任务来提供帮助，这些任务如果由人类完成则非常耗时。因此，人工智慧正越来越多地应用于各个领域，包括药物发现、临床试验计划和患者招募、药物监测（副作用检测）、真实世界证据研究、精准医疗，甚至销售预测和供应链分析。

生命科学分析人工智慧的市场动态

政府主导的研发资金激增和临床试验的增加正在加速人工智慧在生命科学分析领域的应用。

推动生命科学分析领域人工智慧市场发展的主要因素之一是政府对生物医学研发投入的不断增加。同时，临床研究数量的持续成长和追踪意味着研究人员需要处理大量数据，这使得人工智慧分析从「锦上添花」变成了「必不可少」。根据美国国立卫生研究院 (NIH) 的数据，其 2023 财年的预算授权为 475 亿美元，2024 财政年度将增加至 486 亿美元。这笔资金支持了许多大型研究项目，这些项目会产生复杂的数据集（例如基因组数据和临床数据），而这些数据集需要高级分析技术来处理。此外，根据美国政府审核局 (GAO) 称，美国国立卫生研究院 (NIH) 用于人工智慧相关研究的支出授权将从 2018 财年的约 15 亿美元增加到 2022 财年的约 23 亿美元，这标誌着政府主导的人工智慧活动在医疗和科学领域的扩展，以及人工智慧工具在现实世界中应用案例的人工智慧工具增加。在临床研究领域，根据 ClinicalTrials.gov（美国国家医学图书馆，美国政府）的数据，2023 年註册的研究数量超过约 47.7 万项，预计 2024 年将达到约 50 万项。这表明临床研究正在快速发展，而处理如此大量研究的机构将需要人工智慧分析来处理诸如患者资料分类、安全讯号监测和快速发现洞见等任务。总体而言，2022 年至 2024 年政府公布的这些数据显示了一个明显的趋势：资助的研究和临床试验的增加产生了更多的数据，这直接推动了对基于人工智慧的生命科学分析的需求。

生命科学分析领域的人工智慧市场：細項分析

临床试验和云端部署是推动生命科学分析领域人工智慧强劲需求的两大细分市场，其驱动力来自指数级增长的数据量和对可扩展计算的需求。临床研究活动的持续扩展，直接增加了需要清理、监控和报告的结构化和非结构化试验资料量。根据美国国家医学图书馆的ClinicalTrials.gov网站显示，其註册量在2024年超过50万（高于2023年的40万左右）。这表明试验记录和相关文件的数量稳步增长，而人工智慧分析正被广泛应用于可行性评估、患者匹配、通讯协定监控和快速洞察生成。药物安全监测也为临床试验和上市后监测带来了另一个主要数据流。据美国食品药物管理局(FDA) 称，近年来，FDA不利事件报告系统 (FAERS) 每年接受超过 200 万份不利事件报告，因此对人工智慧驱动的病例处理、重复检测和讯号检测的需求不断增长，以应对规模化问题。

同时，基于云端的部署非常适合生命科学分析，因为它们为大型资料集和模型训练提供了灵活的储存和运算能力。根据美国国家标准与技术研究院 (NIST) 的说法，联邦云端指南和定义（包括 SP 800-145 等出版物以及相关的云端安全指南，这些指南将在 2020 年至 2024 年期间被积极引用）将继续规范云端使用和安全的基本要求，从而支持受监管的分析工作负载更广泛地采用云端环境。总体而言，临床试验数量的增加、安全性报告水准的提高以及标准化云端框架的建立，将推动 2020 年至 2025 年间生命科学工作流程中人工智慧分析的广泛应用。

生命科学分析人工智慧市场—区域分析

北美地区凭藉其高额的科学研究投入、大规模的临床研究活动以及成熟的受监管医疗数据数位基础设施，仍然是生命科学分析领域人工智慧最具吸引力的地区之一。根据美国国立卫生研究院 (NIH) 的数据，其预算授权将从 2021 财年的 429 亿美元增长至 2022 财年的 450 亿美元、2023 财年的 475 亿美元和 2024 财年的 486 亿美元，用于支持生物医学研究。生物医学研究通常会产生大量数据，需要自动化和进阶分析。临床研究的数量也清楚地显示了对分析的巨大需求。根据美国国家医学图书馆的 ClinicalTrials.gov 网站的数据，到 2024 年，註册的研究数量将超过 50 万项，这凸显了临床试验相关数据集的规模之大，而人工智慧工具正被用于这些数据集的可行性分析、患者识别支援、监测和报告。上市后数据和安全性数据将进一步增加分析工作流程的压力。据美国食品药物管理局(FDA) 称，FDA不利事件报告系统 (FAERS) 在 2020 年代每年接受超过 200 万份不利事件报告，这推动了对人工智慧驱动的病例处理和讯号检测的需求。

美国生命科学分析人工智慧市场—国家分析

由于美国政府投入的资金规模庞大且稳定，以及受监管的资料流，因此被视为该市场中最具潜力的单一国家。据美国国立卫生研究院 (NIH) 称，其预算授权将在 2024 财年达到 486 亿美元，延续了 2022 财年 450 亿美元的成长势头。这为研究网络产生大规模临床和体学数据集提供了支持。临床试验的规模也反映了研究活动的活跃程度。根据 ClinicalTrials.gov 数据显示，到 2024 年，註册试验的总数将超过 50 万项，这将支撑试验计划、运行监测和结果分析方面分析需求的持续增长。安全报告数量的不断增加进一步强化了自动化技术的商业价值。据美国食品药物管理局 (FDA) 称，预计 2020 年代，药品和医疗设备安全报告系统 (FAERS) 每年将收到超过 200 万份报告，这将持续推动对人工智慧的需求，以辅助病例分诊、发现说明文本中的模式并快速检测安全信号。

目录

第一章 生命科学分析人工智慧市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：生命科学分析领域人工智慧的关键市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

4. 生命科学分析领域的人工智慧市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章 生命科学分析人工智慧市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：生命科学分析人工智慧市场格局

  • 生命科学分析人工智慧市场份额分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 生命科学分析领域的人工智慧市场（依产品/服务分类）

  • 概述
    • 细分市场占有率分析：透过提供
    • 软体
    • 服务

第八章：生命科学分析人工智慧市场（以部署方式划分）

  • 概述
    • 细分市场占有率分析：依部署方式
    • 基于云端的
    • 本地部署

9. 生命科学分析人工智慧市场（按应用领域划分）

  • 概述
    • 细分市场占有率分析：按应用
    • 药物发现与开发
    • 临床试验
    • 销售与行销（商业分析）
    • 供应炼和製造

第十章：生命科学分析人工智慧市场（以最终用户划分）

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 製药公司
    • 生技公司
    • CRO（委外研发机构）
    • 医院、诊所、研究机构

第十一章：生命科学分析人工智慧市场（按地区划分）

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十二章 主要供应商分析：生命科学分析产业的AI

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Accenture
    • Amazon Web Services（AWS）
    • Capgemini
    • Cognizant
    • Databricks
    • Deloitte
    • Google（Google Cloud）
    • IBM
    • Infosys
    • IQVIA
    • Microsoft
    • NVIDIA
    • Oracle
    • Palantir Technologies
    • SAP
    • SAS
    • Snowflake
    • Tata Consultancy Services（TCS）
    • Tempus
    • Wipro
    • Others

第十三章：分析师视角360度分析

简介目录
Product Code: ANV5922

AI in Life Science Analytics Market size was valued at US$ 2,105.3 Million in 2024, expanding at a CAGR of 11.45% from 2025 to 2032.

The AI in Life Science Analytics market primarily involves utilizing AI (such as machine learning, NLP, and various generative AI tools) to process the vast amount of data that life science companies encounter and to make informed decisions more efficiently. Pharma and biotech companies collect data from a lot of places like genomics/omics research, lab experiments, clinical trials, safety reports, scientific papers, and real-world data such as EHRs and insurance claims. The problem is that this data is messy and spread out, and a lot of it is unstructured (for example, doctor notes or medical literature). AI helps by finding patterns, predicting outcomes, and automating parts of analysis that would take humans way longer. That's why it's being used more in things like drug discovery, clinical trial planning and patient recruitment, pharmacovigilance (detecting side effects), real-world evidence studies, precision medicine, and even sales forecasting and supply chain analytics.

AI In Life Science Analytics Market- Market Dynamics

Surging Government-Backed R&D Funding and Clinical-Trial Volume Are Accelerating AI Adoption in Life Science Analytics

One big driver for the AI in Life Science Analytics market is that governments are putting more money into biomedical R&D, and, at the same time, the number of clinical studies being run and tracked keeps increasing so the amount of data researchers have to deal with is getting huge, and AI analytics becomes a practical need rather than a "nice to have." According to the U.S. National Institutes of Health (NIH), the NIH budget authority was $47.5 billion in FY2023 and increased to $48.6 billion in FY2024, which supports a lot of large research programs that generate complex datasets (like genomics and clinical data) that typically require advanced analytics. Also, according to the U.S. Government Accountability Office (GAO), NIH obligations for AI-related research rose from about $1.5 billion in FY2018 to about $2.3 billion in FY2022, showing that government-backed AI activity in health and science is expanding and creating more real use cases for AI tools. On the clinical research side, According to ClinicalTrials.gov (U.S. National Library of Medicine, U.S. government), there were over ~477,000 registered studies in 2023, and this went above ~500,000 studies by 2024, which basically shows how fast clinical research is scaling up; with that many studies, organizations need AI analytics to handle tasks like sorting patient data, monitoring safety signals, and finding insights faster. Overall, these 2022-2024 government-reported numbers point to a clear trend: more funded research plus more trials equals more data, and that directly boosts demand for AI-based life science analytics.

AI In Life Science Analytics Market- Segmentation Analysis:

Clinical trials and cloud-based deployment are two segments that strongly support demand in the AI in Life Science Analytics market because both are tied to fast-growing data volumes and the need for scalable computing. Clinical research activity keeps expanding, and that directly increases the amount of structured and unstructured trial data that must be cleaned, monitored, and reported. According to ClinicalTrials.gov (U.S. National Library of Medicine), the registry crossed 500,000+ registered studies in 2024 (rising from the high-400,000s in 2023), which signals a steady increase in trial records and related documentation where AI analytics is commonly used for feasibility, patient matching, protocol monitoring, and faster insight generation. Drug-safety monitoring adds another large data stream connected to trials and post-market surveillance; according to the U.S. Food and Drug Administration (FDA), the FDA Adverse Event Reporting System (FAERS) has been receiving over 2 million adverse event reports per year in recent years across the 2020s, creating ongoing demand for AI-driven case processing, duplicate detection, and signal detection to manage scale.

At the same time, cloud-based deployment fits life science analytics because it provides flexible storage and compute for large datasets and model training; according to the U.S. National Institute of Standards and Technology (NIST), federal cloud guidance and definitions (including publications actively referenced through 2020-2024, such as SP 800-145 and related cloud security guidance) continue to formalize baseline expectations for cloud usage and security, supporting broader adoption of cloud environments for regulated analytics workloads. Overall, rising clinical study counts, high safety-report volumes, and standardized cloud frameworks together support stronger use of AI analytics across life science workflows between 2020 and 2025.

AI In Life Science Analytics Market- Geographical Insights

North America remains one of the most attractive regions for AI in life science analytics because the region combines high research spending, large clinical research activity, and mature digital infrastructure for regulated health data. According to the U.S. National Institutes of Health (NIH), NIH budget authority increased from $42.9 billion (FY2021) to $45.0 billion (FY2022), then to $47.5 billion (FY2023) and $48.6 billion (FY2024), which supports a huge amount of data-producing biomedical research that typically needs automation and advanced analytics. Clinical research volume is also a strong signal of analytics demand; according to ClinicalTrials.gov (U.S. National Library of Medicine), the registry exceeded 500,000+ studies by 2024, highlighting the scale of trial-related datasets where AI tools are used for feasibility analytics, patient identification support, monitoring, and reporting. Post-market and safety data add even more pressure on analytics workflows; according to the U.S. Food and Drug Administration (FDA), the FDA Adverse Event Reporting System (FAERS) receives more than 2 million adverse event reports per year in the 2020s, which increases the need for AI-driven case processing and signal detection.

United States AI in Life Science Analytics Market- Country Insights

The United States is typically viewed as the strongest single-country opportunity in this market because government-backed spending and regulated data streams are unusually large and consistent. According to the NIH, budget authority reached $48.6 billion in FY2024, continuing growth from $45.0 billion in FY2022, and supporting research networks that generate large-scale clinical and omics datasets. Research activity is also reflected in clinical trial scale; according to ClinicalTrials.gov, total registered studies crossed 500,000+ in 2024, which supports steady demand for analytics across trial planning, operational oversight, and outcome analysis. Safety reporting volumes further strengthen the business case for automation; according to the FDA, FAERS receives 2 million+ reports annually in the 2020s, creating ongoing demand for AI that can triage cases, find patterns in narrative text, and support faster detection of safety signals.

AI In Life Science Analytics Market- Competitive Landscape:

The competitive landscape is shaped by the ability to manage regulated data at scale, connect multiple life science datasets, and deploy AI models in production with audit-ready governance. Major vendors typically referenced in this space include SAS (strength in statistical analytics and governance for regulated environments), IBM (strength in enterprise AI and NLP for unstructured text analytics), Oracle (strength in life-science data systems and scalable cloud infrastructure), Microsoft (strength in enterprise cloud and AI services with security controls), AWS (strength in elastic compute and data services for large-scale analytics), Google Cloud (strength in data engineering and AI/ML tooling at scale), IQVIA (strength in real-world data/real-world evidence and commercial analytics), and Veeva (strength in life-sciences workflows and commercial content/data management). Strong public indicators reported between 2020-2025 including rising NIH funding according to NIH, growing trial registration totals according to ClinicalTrials.gov, and high annual safety-report inflow according to FDA tend to favor vendors that can deliver compliant analytics, support high-volume pipelines, and integrate across clinical, safety, and R&D environments.

Recent Developments:

In December 2025, Medicus Pharma Ltd., a precision-guided biotech/life sciences company, announced a non-binding letter of intent (LOI) with Reliant AI Inc., a life-sciences decision-intelligence company focused on generative AI, to work on an AI-powered data analytics platform aimed at improving clinical trial execution using data-driven insights, with planned capabilities such as dynamic site selection, patient stratification, and enrollment forecasting, and an initial focus on dynamic site selection and targeted stratification for an upcoming Teverelix clinical study expected to begin in 2026.

In June 2025, IQVIA, a global provider of clinical research services, commercial insights, and healthcare intelligence for life sciences, unveiled new custom AI agents at GTC Paris built using NVIDIA technology to improve workflows and speed up insights, with use cases highlighted across target identification, clinical data review, literature review, market assessment, and HCP engagement, following a strategic collaboration announced in January to develop custom foundation models and agentic AI workflows to support research, clinical development, and treatment access.

In February 2025, Medidata (Dassault Systemes), a clinical development solutions provider for biopharma, reaffirmed its plan to expand AI and virtual-twin capabilities across the clinical development process, describing how generative experiences using synthetic data can simulate virtual patient cohorts to improve trial performance and reduce exposure to experimental therapies, and noting that Medidata works with 19 of the top 20 pharmaceutical companies while leveraging a large patient-level historical clinical trial dataset to support patient-centric trial and post-trial outcomes programs.

In June 2025, the U.S. Food and Drug Administration (FDA), the U.S. federal regulator for drugs and medical products, announced an agency-wide expansion of its internal generative AI tool Elsa by June 30, 2025, stating that the system runs in a secure GovCloud environment to help staff with clinical protocol assessments, safety evaluations, and internal workflow efficiency, and adding that Elsa does not train on regulated-industry-submitted data to protect confidential and proprietary information.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Accenture
  • Amazon Web Services (AWS)
  • Capgemini
  • Cognizant
  • Databricks
  • Deloitte
  • Google (Google Cloud)
  • IBM
  • Infosys
  • IQVIA
  • Microsoft
  • NVIDIA
  • Oracle
  • Palantir Technologies
  • SAP
  • SAS
  • Snowflake
  • Tata Consultancy Services (TCS)
  • Tempus
  • Wipro
  • Others

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032

  • Cloud-based
  • On-premises

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery & Development
  • Clinical Trials
  • Sales & Marketing (Commercial Analytics)
  • Supply Chain & Manufacturing

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals/Clinics & Research Institutes

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI In Life Science Analytics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI In Life Science Analytics Market Snippet by Offering
    • 2.1.2. AI In Life Science Analytics Market Snippet by Deployment Mode
    • 2.1.3. AI In Life Science Analytics Market Snippet by Application
    • 2.1.4. AI In Life Science Analytics Market Snippet by End User
    • 2.1.5. AI In Life Science Analytics Market Snippet by Country
    • 2.1.6. AI In Life Science Analytics Market Snippet by Region
  • 2.2. Competitive Insights

3. AI In Life Science Analytics Key Market Trends

  • 3.1. AI In Life Science Analytics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI In Life Science Analytics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI In Life Science Analytics Market Opportunities
  • 3.4. AI In Life Science Analytics Market Future Trends

4. AI In Life Science Analytics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI In Life Science Analytics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. AI In Life Science Analytics Market Landscape

  • 6.1. AI In Life Science Analytics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI In Life Science Analytics Market - By Offering

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Offering, 2024 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services

8. AI In Life Science Analytics Market - By Deployment Mode

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment Mode, 2024 & 2032 (%)
    • 8.1.2. Cloud-based
    • 8.1.3. On-premises

9. AI In Life Science Analytics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery & Development
    • 9.1.3. Clinical Trials
    • 9.1.4. Sales & Marketing (Commercial Analytics)
    • 9.1.5. Supply Chain & Manufacturing

10. AI In Life Science Analytics Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Deployment Mode, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Contract Research Organizations (CROs)
    • 10.1.5. Hospitals/Clinics & Research Institutes

11. AI In Life Science Analytics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. AI In Life Science Analytics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. AI In Life Science Analytics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. AI In Life Science Analytics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. AI In Life Science Analytics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. AI In Life Science Analytics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- AI In Life Science Analytics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Accenture
    • 12.2.2. Amazon Web Services (AWS)
    • 12.2.3. Capgemini
    • 12.2.4. Cognizant
    • 12.2.5. Databricks
    • 12.2.6. Deloitte
    • 12.2.7. Google (Google Cloud)
    • 12.2.8. IBM
    • 12.2.9. Infosys
    • 12.2.10. IQVIA
    • 12.2.11. Microsoft
    • 12.2.12. NVIDIA
    • 12.2.13. Oracle
    • 12.2.14. Palantir Technologies
    • 12.2.15. SAP
    • 12.2.16. SAS
    • 12.2.17. Snowflake
    • 12.2.18. Tata Consultancy Services (TCS)
    • 12.2.19. Tempus
    • 12.2.20. Wipro
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us